#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinaemic hypoglycaemia Burkitt's lymphoma refractory Infantile apnoea Myeloproliferative neoplasm Gaucher's disease type III Chronic granulomatous disease Thrombotic thrombocytopenic purpura Ovarian cancer stage III Hereditary neuropathic amyloidosis Glioblastoma multiforme Mucopolysaccharidosis II Chondrosarcoma metastatic Pleomorphic liposarcoma Fms-like tyrosine kinase 3 positive Anaplastic large cell lymphoma T- and null-cell types More trials…

    Learn about Rare Diseases

    Sarcoma Osteosarcoma metastatic – Life with Disease Chronic granulomatous disease – Treatment Shprintzen-Goldberg syndrome – Life with Disease Paraneoplastic neurological syndrome – Life with Disease Noonan syndrome – Trials in Disease MELAS syndrome – Treatment Leiomyosarcoma metastatic Glomerulonephritis rapidly progressive Malignant fibrous histiocytoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ro7790121 Levocabastine Hydrochloride Flecainide Acetate HYDROXYCHLOROQUINE Midodrine Hydrochloride Bms-986315 Rosuvastatin Zinc Staphylococcus Aureus Temozolomide Levosimendan VOXVOGANAN VG801-2 Ltp001 Asciminib Hydrochloride Sodium Thiosulfate Betula Pendula Pollen Extract Teprotumumab AZD5335 IMMUNOSTEM MAGNESIUM ACETATE TETRAHYDRATE More therapies…

    Learn about Your Condition

    Hypertrophic scar Dementia Alzheimer's type Acute cardiac event HER2 positive gastric cancer Acute myeloid leukaemia Huntington's disease Hypoxia Oesophageal achalasia Nephroblastoma Primary adrenal insufficiency Endometrial cancer stage IV Petit mal epilepsy Urticaria Cutibacterium acnes infection Multifocal motor neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Evaluating Treatment with Autologous Regulatory T-cells Given by Infusion in Adults with Ulcerative Colitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • AUTOLOGOUS REGULATORY T-CELLS WITH AN IMMUNOPHENOTYPE OF CD4+CD25HI/+FOXP3+
    Germany

  • Study of eplerenone in patients with heart failure and reduced ejection fraction who also have severe chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Altizide
    • Micronised Spironolactone
    Sweden

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of elexacaftor, tezacaftor and ivacaftor combination therapy to evaluate blood levels in patients with Cystic Fibrosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Elexacaftor
    • Ivacaftor
    • Tezacaftor
    Italy

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Hidradenitis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    Germany Spain
Previous Page
1 … 776 777 778 779 780 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!